Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered by 500 mg IV Bolus Injection or 1000 mg Intravenous Infusion to Patients With Non-hematological Malignancies Associated With Chemotherapy Induced Anaemia (CIA)

NCT01213979 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-hematological Malignancies

Interventions

DRUG: 500 mg iron isomaltoside 1000
DRUG: 1000 mg iron isomaltoside 1000

Sponsor

Pharmacosmos A/S